Crinetics Pharmaceuticals Inc Share Price: CRNX (Crinetics Pharmaceuticals Inc) Stock Price Today & Updates | INDmoney

Question 1

What is Crinetics Pharmaceuticals Inc share price today?

Accepted Answer

Crinetics Pharmaceuticals Inc (CRNX) share price today is {{live_price}}.

Question 2

Can Indians buy Crinetics Pharmaceuticals Inc shares?

Accepted Answer

Yes, Indians can invest in the Crinetics Pharmaceuticals Inc (CRNX) from India.

With INDmoney, you can buy Crinetics Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Crinetics Pharmaceuticals Inc at zero transaction cost.

Question 3

How can I buy Crinetics Pharmaceuticals Inc shares from India?

Accepted Answer

It is very easy to buy Crinetics Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Crinetics Pharmaceuticals Inc be purchased?

Accepted Answer

Yes, you can buy fractional shares of Crinetics Pharmaceuticals Inc with INDmoney app.

Question 5

What are the documents required to start investing in Crinetics Pharmaceuticals Inc stocks?

Accepted Answer

To start investing in Crinetics Pharmaceuticals Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Crinetics Pharmaceuticals Inc

Accepted Answer

Today’s highest price of Crinetics Pharmaceuticals Inc (CRNX) is {{1_rba_end}}.

Today’s lowest price of Crinetics Pharmaceuticals Inc (CRNX) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Crinetics Pharmaceuticals Inc

Accepted Answer

Today's market capitalisation of Crinetics Pharmaceuticals Inc CRNX is 3.9B

Question 8

What is the 52 Week High and Low Range of Crinetics Pharmaceuticals Inc

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Crinetics Pharmaceuticals Inc is down from its 52 Week High?

Accepted Answer

Crinetics Pharmaceuticals Inc (CRNX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Crinetics Pharmaceuticals Inc is up from its 52 Week low?

Accepted Answer

Crinetics Pharmaceuticals Inc (CRNX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Crinetics Pharmaceuticals Inc?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Crinetics Pharmaceuticals Inc

Accepted Answer

Dr. R. Scott Struthers Ph.D. is the current Chief Executive Officer (CEO) of Crinetics Pharmaceuticals Inc.

Period	Crinetics Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	33.5%	0.4%	0.0%
6 Months	78.16%	14.0%	0.0%
1 Year	128.36%	11.6%	-0.3%
3 Years	203.24%	18.6%	-20.6%

Market Capitalization	4.0B
Book Value	$11.14
Earnings Per Share (EPS)	-3.77
Wall Street Target Price	62.77

Profit Margin	0.0%
Operating Margin TTM	-11488.91%

Return On Assets TTM	-24.01%
Return On Equity TTM	-40.76%

Revenue TTM	2.0M
Revenue Per Share TTM	0.03
Quarterly Revenue Growth YOY	-76.1%
Gross Profit TTM	-125.5M
EBITDA	-246.9M
Diluted Eps TTM	-3.77
Quarterly Earnings Growth YOY	0.0

Crinetics Pharmaceuticals Inc (CRNX)

Increasing Revenue

Decreasing Net Profit

Vs NVO

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Institutional Holdings

Corporate Announcements

Crinetics Pharmaceuticals Inc Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-3.52
EPS Estimate Next Year	-3.79
EPS Estimate Current Quarter	-0.81
EPS Estimate Next Quarter	-0.8

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Crinetics Pharmaceuticals Inc	16.1%	78.16%	128.36%	203.24%	97.38%
Moderna, Inc.	24.35%	68.6%	3.16%	-19.55%	450.13%
Regeneron Pharmaceuticals, Inc.	8.55%	21.91%	30.49%	86.78%	220.79%
Novo Nordisk A/s	6.83%	35.3%	59.23%	234.23%	468.67%
Vertex Pharmaceuticals Incorporated	11.29%	24.82%	28.22%	102.21%	159.28%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Crinetics Pharmaceuticals Inc	NA	NA	NA	-3.52	-0.41	-0.24	NA	11.14
Moderna, Inc.	24.73	NA	0.0	-7.14	-0.38	-0.16	NA	33.47
Regeneron Pharmaceuticals, Inc.	29.07	29.07	1.46	44.2	0.15	0.08	NA	250.15
Novo Nordisk A/s	46.14	46.14	2.36	3.46	1.0	0.25	0.01	22.18
Vertex Pharmaceuticals Incorporated	27.78	27.78	0.53	17.1	0.24	0.13	NA	71.8

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Crinetics Pharmaceuticals Inc	Buy	$3.9B	97.38%	NA	0.0%
Moderna, Inc.	Buy	$49.2B	450.13%	24.73	-115.82%
Regeneron Pharmaceuticals, Inc.	Buy	$107.6B	220.79%	29.07	29.45%
Novo Nordisk A/s	Buy	$589.9B	468.67%	46.14	36.55%
Vertex Pharmaceuticals Incorporated	Buy	$110.9B	159.28%	27.78	39.46%

Organization	Crinetics Pharmaceuticals Inc
Employees	290
CEO	Dr. R. Scott Struthers Ph.D.
Industry	Health Technology